iGMDRD157
Canonical SMILES: CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O
InChI: InChI=1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1
InChI Key: LPMXVESGRSUGHW-HBYQJFLCSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard NameOuabain CHEMBLCHEMBL222863 Pubchem CID439501 KEGG Drug IDD00112 DRUGBANK IDDB01092 Drug StatusAlone Drug targets (TTD)DAP000465 Drug TypeSmall Molecule |
Drug Class:
CarbohydratesCardanolidesCardenolidesCardiac GlycosidesCardiac TherapyCardiotonic AgentsCardiovascular AgentsCardiovascular SystemEnzyme InhibitorsGlycosidesPolycyclic CompoundsProtective AgentsSpecialty Uses of ChemicalsSteroidsStrophanthinsStrophanthus GlycosidesDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Ouabain
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |